Subiaco-based Phylogica has secured a signficant shareholding in Dynamic Microbials, with the two companies signing an exclusive Licence Agreement for Phylogica's anti-bacterial applications.
The new agreement is a step forward in addressing concernes expressed by pharmaceutical industry stakeholders about the lack of new antibiotic drugs and the underdevelopment of drug pipelines in this area.
Article continues...
This content you are trying to access is locked for subscribers only.